CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
smoking cessation +3 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000508
NCT00000508Phase 3Completed
CompareCT.gov

Stanford Coronary Risk Intervention Project (SCRIP)

Stanford University·interventional·Posted Oct 28, 1999·Updated Jan 12, 2016

In Brief

A Phase 3 clinical trial evaluating smoking cessation, diet, reducing, and 2 other interventions for Cardiovascular Diseases and 4 related conditions. Completed.

Detailed Summary

To determine whether modification of risk factors altered the rate of progression of coronary artery disease in arteries with mild atherosclerosis and no mechanical intervention in patients who had coronary bypass surgery or percutaneous transluminal coronary angioplasty (PTCA).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Coronary Arteriosclerosis, Coronary Disease, Heart Diseases, Myocardial Ischemia
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

Phase 3CompletedFinished
198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartSep 1, 1983
Study CompletionMar 1, 1993
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

smoking cessationbehavioral

diet, reducingbehavioral

exercisebehavioral

diet, fat-restrictedbehavioral